Resources with keywords: shipping



Outbreak of Ebola virus disease (Sudan ebolavirus) in Central Uganda
CDC/Health Alert Network
6 October 2022

The CDC is reporting a recently confirmed outbreak of Ebola virus disease (EVD) in Uganda caused by Sudan virus (species Sudan ebolavirus) to summarize CDC’s recommendations for U.S. public health departments and clinicians, case identification and testing, and clinical laboratory biosafety considerations.

Ebola (Ebola Virus Disease): Guidance for Collection, Transport and Submission of Specimens for Ebola Virus Testing
CDC
Ebola (Ebola Virus Disease): Laboratory Testing
CDC

US Guidance for speciment collection, transport and submission. Management of routine clinical samples is also included

Transporting Infectious Substances safely
US Department of Transportation

This document includes Monkeypox in the EXAMPLE OF CATEGORY A: UN2814, INFECTIOUS SUBSTANCES AFFECTING HUMANS

keywords: Monkeypox, shipping
SARS-CoV-2 Specimens: Packing and Shipping (NEW 6/23, Document, Regulatory)
CDC

Quick reference guide adapted from the CDC Laboratory Training course for shipping Covid samples.

Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives (Website, Publication)
American Society for Microbiology (ASM)

Welch SR. et al.

Import Permit Program (IPP) (Website, Regulatory)
CDC

This site includes updated information on importing SARS-CoV-2 isolates, cultures or fluids reasonably expected to contain SARS-CoV-2.

Includes a FAQs on import permits in the US, including questions about SARS-CoV-2

keywords: covid-19, shipping
Novel Coronavirus (COVID-19): Guidance for Operators (Document)
IATA

Includes guidance to ship viral stocks and cultures of SARS-CoV-2 as Category A, UN 2814, Infectious substance, affecting humans (SARS-CoV-2).

keywords: covid-19, shipping
Transport Media Safety Risk - Use Compatible Transport Media with SARS-CoV-2 Tests that Use Bleach - Letter to Clinical Laboratory Staff and Health Care Providers (Website, Regulatory)
FDA
1 June 2020

FDA issued a letter to clinical laboratory staff about a safety risk with using transport media and SARS-CoV-2 testing platforms that are not compatible.

SARS-CoV-2 Packaging and Shipping Information (Document)
ABSA: Emerging Infectious Diseases Committee (EIDC)
1 June 2020
Go to Top